Spruce Biosciences, Inc.
SPRB and SPRBD • NASDAQ
Spruce Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Javier Szwarcberg, with a market cap of $75.8M.
CEOJavier Szwarcberg
Market Cap$75.8M
Biotechnology
Healthcare
Employees22.0
Websitesprucebiosciences.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Spruce Biosciences, Inc.
Date
Tuesday, May 5, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$12.99
Earnings History
Past 11 earnings reports for Spruce Biosciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$14.58Est: -$15.56 | +6.3% | -Est: $200.0K | -100.0% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$3.50Est: -$20.25 | +82.7% | -Est: $200.0K | -100.0% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.32Est: -$0.20 | -60.0% | -Est: $500.0K | -100.0% | 10-Q |
| Apr 15, 2025 | Q4 2024 | -$0.57Est: -$0.20 | -185.0% | $697.0KEst: $885.0K | -21.2% | 10-K |
| Nov 11, 2024 | Q3 2024 | -$0.21Est: -$0.24 | +12.5% | $602.0KEst: $1.5M | -59.6% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.22Est: -$0.30 | +26.7% | $1.6MEst: $1.5M | +7.7% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.28Est: -$0.29 | +3.4% | $2.0MEst: $1.2M | +74.1% | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$0.23Est: -$0.39 | +41.0% | $2.9MEst: $1.4M | +106.2% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.30Est: -$0.35 | +14.3% | $3.1MEst: $1.5M | +104.9% | — |
| Aug 14, 2023 | Q2 2023 | -$0.32Est: -$0.39 | +17.9% | $2.2MEst: $820.0K | +164.0% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.40Est: -$0.36 | -11.1% | $2.0MEst: $500.0K | +292.8% | 10-Q |